Description ECHO MS implements the evidence-based hub and spoke ECHO model™ to create a dynamic learning community between MS expert hub teams and community based MS healthcare providers. The National MS Society operates three hub teams in three time zones: Eastern, Central and Pacific. The hub teams facilitate 12 interactive video conference sessions over a …
Author Archives: [email protected]
Clients with MS: Do No Harm
July 17, 2021 (Virtual) 12:00pm – 3:00pm (ET); 9:00am – 12:00pm (PT) Continuing Education Credit Available for Psychologists and Social Workers. Target Audience This activity has been designed to meet the educational needs of psychologists, social workers, and other members of the healthcare team involved in the management of patients with MS. Learning Objectives Upon …
IJMSC: Trekking Poles to Aid Multiple Sclerosis Walking Impairment: An Exploratory Comparison of the Effects of Assistive Devices on Psychosocial Impact and Walking
Release Date: June1, 2021 Valid for Credit Through: June 1, 2022 Trekking Poles to Aid Multiple Sclerosis Walking Impairment: An Exploratory Comparison of the Effects of Assistive Devices on Psychosocial Impact and Walking Evan T. Cohen, PhD; Sara Huser, DO; Kathleen Barone, BSN; Donald A. Barone, DO Target Audience: The target audience for this activity …
Expert Insights on COVID-19 Vaccinations and High-Efficacy Therapies for Multiple Sclerosis
IJMSC: Variables Associated with Self-reported Language Impairment in Multiple Sclerosis: A Regression Analysis
Release Date: April1, 2021 Valid for Credit Through: April 1, 2022 Variables Associated with Self-reported Language Impairment in Multiple Sclerosis: A Regression Analysis Sarah El-Wahsh, BAppSc (Sp Path) (Hons 1); Rob Heard, PhD; Hans Bogaardt, PhD; Fiona Kumfor, PhD; Kirrie J. Ballard, PhD Target Audience: The target audience for this activity is physicians, physician assistants, …
Therapeutic Advances in the Management of Relapsing Forms of Multiple Sclerosis
Release Date: 3/12/2021 Expiration Date: 3/11/2022 Provider Statement This continuing education activity is provided by Support Statement This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation. Target Audience The intended audience for this activity is neurologists, neurology nursing professionals, pharmacists, physician assistants, and other health care professionals involved in the management …
Continue reading “Therapeutic Advances in the Management of Relapsing Forms of Multiple Sclerosis”
AIMS Peer-to-Peer Podcasts
New Podcasts Available for Clinicians to Earn CE Credit! Earn up to 0.75 CE Credits Sit back and listen to three exciting and insightful podcasts from top MS experts. Featuring discussions on the clinical course of MS (Drs. Fred Lublin and Robert Shin), MS assessment (Drs. Patricia Coyle and Robert Shin), and shared decision-making strategies …
MS Forum® 2021, Session 1 – April 10
This two-part CE webinar series aims to provide guidance on the appropriate use of therapies and strategies for delivering individualized care to patients with multiple sclerosis (MS). This series will incorporate case discussions and a live question-and-answer session.
MS Forum® 2021, Session 2 – April 24
This two-part CE webinar series aims to provide guidance on the appropriate use of therapies and strategies for delivering individualized care to patients with multiple sclerosis (MS). This series will incorporate case discussions and a live question-and-answer session.
Immune Dysfunction in Multiple Sclerosis: Modern Considerations in Treatment and Management
Released: January 11, 2021 Expires: January 11, 2022 Program Description This activity provides an overview of the role of the innate and adaptive immune systems in the development and progression of multiple sclerosis (MS), while exploring the therapeutic implications of immune dysfunction. MS immunotherapies are reviewed, with a focus on their mechanisms of action and …